Business Weekly2 小时
First patient dosed in Microbiotica’s COMPOSER-1 trial
Cambridge biopharma company Microbiotica reveals that the first patient has been dosed in its Phase 1b First-in-Human trial, ...
Business Weekly20 小时
lowRISC and SCI Semiconductor on song as Sonata transforms open source design
Cambridge UK tech trailblazers lowRISC C.I.C. and SCI Semiconductor have unveiled a drive to tapeout the Sonata™ design, in ...
Business Weekly22 小时
AstraZeneca investing $3.5bn in R & D and manufacturing in the US
AstraZeneca, headquartered in Cambridge UK but globally influential, is investing $3.5 billion in the United States to expand ...